Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Neuropharmacology

• Publication date

  2004-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.NEUROPHARM.2004.01.018PMID 15081787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats

  2004cited by this paper
• Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders

  2003cited by this paper
• Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans

  2003cited by this paper
• Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia

  2002cited by this paper
• Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2 -/- mice.

  2002cited by this paper
• Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1.

  2001cited by this paper
• Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites.

  2001cited by this paper
• Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task

  2001cited by this paper
• Chapter 1. Metabotropic glutamate receptor modulators: Recent advances and therapeutic potential

  2000cited by this paper
• Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors

  2000cited by this paper
• A cortical–hippocampal system for declarative memory

  2000cited by this paper
• Chapter III Metabotropic glutamate receptors — immunocytochemical and in situ hybridization analyses

  2000cited by this paper
• Synthesis of (2S, 2'R, 3'R)-2-(1'-[3H], 2', 3'-dicarboxylcyclopropyl)-glycine ([3H]-DCG-IV)

  2000cited by this paper
• Metabotropic glutamate receptors: electrophysiological properties and role in plasticity.

  1999cited by this paper
• Dopamine Selectively Inhibits the Direct Cortical Pathway to the CA1 Hippocampal Region

  1999cited by this paper
• Effects of Ibotenate Hippocampal and Extrahippocampal Destruction on Delayed-Match and -Nonmatch-to-Sample Behavior in Rats

  1999cited by this paper
• Pharmacological agents acting at subtypes of metabotropic glutamate receptors.

  1999cited by this paper
• Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody.

  1998cited by this paper
• Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.

  1998cited by this paper
• 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.

  1998cited by this paper
• Cognitive neuroscience and the study of memory.

  1998cited by this paper
• Gamma Oscillations in the Entorhinal Cortex of the Freely Behaving Rat

  1998cited by this paper
• Characterization of perforant path lesions in rodent models of memory and attention

  1998cited by this paper
• In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

  1998cited by this paper
• Characterization of (2S,2′R,3′R)‐2‐(2′,3′‐[3H]‐Dicarboxycyclopropyl)glycine Binding in Rat Brain

  1998cited by this paper
• LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.

  1998cited by this paper
• The delayed-conditional-discrimination task improves measurement of working memory in rats.

  1997cited by this paper
• Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.

  1997cited by this paper
• Differential Presynaptic Localization of Metabotropic Glutamate Receptor Subtypes in the Rat Hippocampus

  1997cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors

  1997cited by this paper
• Life and death of neurons in the aging brain.

  1997cited by this paper
• The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations.

  1996cited by this paper
• Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

  1996cited by this paper
• Cognitive and neurobiologic markers of early Alzheimer disease.

  1996cited by this paper
• Impairment of Hippocampal Mossy Fiber LTD in Mice Lacking mGluR2

  1996cited by this paper
• Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody.

  1996cited by this paper
• Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists

  1995cited by this paper
• Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex.

  1994cited by this paper
• Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ hybridization study

  1993cited by this paper
• Entorhinal-hippocampal connections: a speculative view of their function.

  1993cited by this paper
• Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat.

  1993cited by this paper
• Bilateral knife cuts to the perforant path disrupt spatial learning in the Morris water maze

  1992cited by this paper
• Removal of the hippocampus and transection of the fornix produce comparable deficits on delayed non-matching to position by rats.

  1992cited by this paper
• The medial temporal lobe memory system

  1991cited by this paper
• Rate of forgetting in mild Alzheimer's-type dementia.

  1988cited by this paper

• Coadministration of scopolamine and mGlu2 NAM VU6001966 as a novel antidepressant approach: Lowering effective dose and reducing cognitive side effects.

  2025cites this paper
• Projection-targeted photopharmacology reveals distinct anxiolytic roles for presynaptic mGluR2 in prefrontal- and insula-amygdala synapses.

  2025cites this paper
• Adaptive Changes in Group 2 Metabotropic Glutamate Receptors Underlie the Deficit in Recognition Memory Induced by Methamphetamine in Mice

  2024cites this paper
• Projection-Targeted Photopharmacology Reveals Distinct Anxiolytic Roles for Presynaptic mGluR2 in Prefrontal- and Insula-Amygdala Synapses

  2024cites this paper
• Design, Synthesis, Pharmacology, and In Silico Studies of (1S,2S,3S)-2-((S)-Amino(carboxy)methyl)-3-(carboxymethyl)cyclopropane-1-carboxylic Acid (LBG30300): A Picomolar Potency Subtype-Selective mGlu2 Receptor Agonist.

  2024cites this paper
• Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats

  2024cites this paper
• Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists

  2024cites this paper
• Metabotropic Glutamate Receptor 2 Expression Is Chronically Elevated in Male Rats With Post-Traumatic Stress Disorder Related Behavioral Traits Following Repetitive Low-Level Blast Exposure

  2023cites this paper
• BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy.

  2023cites this paper
• Glutamate receptor endocytosis and signaling in neurological conditions.

  2023cites this paper
• (2R,6R)-Hydroxynorketamine Treatment of Rats Exposed to Repetitive Low-Level Blast Injury

  2023cites this paper
• Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review)

  2023cites this paper
• Impairments in the early consolidation of spatial memories via group II mGluR agonism in the mammillary bodies

  2023cites this paper
• Emerging drugs for the treatment of major depressive disorder

  2022cites this paper
• Clinical investigations of compounds targeting metabotropic glutamate receptors.

  2022cites this paper
• mGluR1α expression in the hippocampus, subiculum, entorhinal cortex and superior temporal gyrus in Alzheimer’s disease

  2022cites this paper
• mGlu2/3 Receptor Antagonists as Rapid-Acting Antidepressants

  2021cites this paper
• Modulation of Hippocampal Network Oscillation by PICK1-Dependent Cell Surface Expression of mGlu3 Receptors

  2021cites this paper
• The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy

  2020cites this paper
• Effects of post-training administration of LY341495, as a mGluR2/3 antagonist on spatial memory deficit in rats fed with high-fat diet CURRENT

  2020cites this paper
• G protein-coupled receptors in neurodegenerative diseases

  2020cites this paper
• LSP2-9166, an orthosteric mGlu4 and mGlu7 receptor agonist, reduces cocaine self-administration under a progressive ratio schedule in rats.

  2020cites this paper
• Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus

  2020cites this paper
• Effects of post-training administration of LY341495, as an mGluR2/3 antagonist on spatial memory deficit in rats fed with high-fat diet

  2020cites this paper
• Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder.

  2020cites this paper
• Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models.

  2020cites this paper
• Curriculum 2013 – Based Assessment to Measure Critical Thinking Skills of Science Teacher at Junior High Scholl Donggala Regency, Indonesia

  2019cites this paper
• Branched Photoswitchable Tethered Ligands Enable Ultra-efficient Optical Control and Detection of G Protein-Coupled Receptors In Vivo.

  2019cites this paper
• mGlu2/3 receptor antagonists.

  2019cites this paper
• Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression

  2018cites this paper
• Metabotropic glutamate receptors: the potential for therapeutic applications in Alzheimer's disease

  2018cites this paper
• PTSD-Related Behavioral Traits in a Rat Model of Blast-Induced mTBI Are Reversed by the mGluR2/3 Receptor Antagonist BCI-838

  2018cites this paper
• Potent and selective pharmacodynamic synergy between the metabotropic glutamate receptor subtype 2–positive allosteric modulator JNJ‐46356479 and levetiracetam in the mouse 6‐Hz (44‐mA) model

  2018cites this paper
• La phosphorylation du récepteur mGlu₂ du glutamate : mécanisme clé de son cross talk fonctionnel avec le récepteur 5-HT2A de la sérotonine

  2018cites this paper
• Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

  2017cites this paper
• Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia

  2017cites this paper
• The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders

  2017cites this paper
• Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders

  2017cites this paper
• NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer’s, and Ethanol Intoxication

  2017cites this paper
• Amyloid‐beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors

  2017cites this paper
• mGlu2/3 Receptor Antagonists as Novel Antidepressants.

  2017cites this paper
• The Relevance of Group II Glutamate Receptors Expression to Anxiety.

  2016cites this paper
• Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

  2016cites this paper
• Metabotropic Glutamate Receptors in Central Nervous System Diseases.

  2016cites this paper
• The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia

  2016cites this paper
• CALCIUM REGULATION OF CELL-CELL COMMUNICATION AND EXTRACELLULAR SIGNALING

  2016cites this paper
• The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2−/−, GRM3−/− and GRM2/3−/− knockout mice

  2015cites this paper
• Role of Group II Metabotropic Glutamate Receptors (mGluR2/3) Blockade on Long-Term Potentiation in the Dentate Gyrus Region of Hippocampus in Rats Fed with High-Fat Diet

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

  2015cites this paper
• Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.

  2015cites this paper
• Behavior in a Conditional Mouse Model of Huntington's Disease Cortical Efferents Lacking Mutant huntingtin Improve Striatal Neuronal Activity and

  2015cites this paper
• Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.

  2015cites this paper
• LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment.

  2015cites this paper
• mGlu 2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu 2 / mGlu 3 receptor agonists

  2015cites this paper
• Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression

  2015cites this paper
• Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: evidence from sleep-wake EEG in rodents.

  2014cites this paper
• Metabotropic glutamatergic receptors and their ligands in drug addiction.

  2014cites this paper
• Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.

  2014cites this paper
• Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

  2014cites this paper
• Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.

  2014cites this paper
• mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests.

  2014cites this paper
• mGlu(2) receptor-mediated modulation of conditioned avoidance behavior in rats.

  2014cites this paper
• mGlu3 receptor and astrocytes: partners in neuroprotection.

  2013cites this paper
• Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.

  2013cites this paper
• Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning.

  2013cites this paper
• Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction

  2013cites this paper
• Synthesis and biological evaluation of novel 2,3-dihydro-1H-1,5-benzodiazepin-2-ones; potential imaging agents of the metabotropic glutamate 2 receptor

  2013cites this paper
• Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning.

  2013cites this paper
• Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

  2013cites this paper
• Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.

  2013cites this paper
• Animal models of working memory: a review of tasks that might be used in screening drug treatments for the memory impairments found in schizophrenia.

  2013cites this paper
• Group II Metabotropic Glutamate Receptor Agonist LY379268 Regulates AMPA Receptor Trafficking in Prefrontal Cortical Neurons

  2013cites this paper
• CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [³H]LY459477 autoradiography.

  2013cites this paper
• Selective activation of either mGlu2 or mGlu3 receptors can induce LTD in the amygdala.

  2013influential citation
• Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.

  2013cites this paper
• NAAG peptidase inhibitors and deletion of NAAG peptidase gene enhance memory in novel object recognition test.

  2013influential citation
• Decreased striatal dopamine in group II metabotropic glutamate receptor (mGlu2/mGlu3) double knockout mice

  2013cites this paper
• Dérivés quinoléine carboxamides et quinoléine carbonitriles en tant que modulateurs allostériques négatifs de mglur2, compositions et leur utilisation

  2012cites this paper
• The metabotropic glutamate 2/3 receptor antagonist LY341495 differentially affects recognition memory in rats.

  2012influential citation
• [Discovery of novel antipsychotics targeting group II metabotropic glutamate receptor].

  2012cites this paper
• Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia.

  2012influential citation
• NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia

  2012cites this paper
• Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

  2012cites this paper
• mGlu Receptors and Cancerous Growth.

  2012cites this paper
• Metabotropic glutamate receptors and cancerous growth

  2012cites this paper
• Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia

  2012cites this paper
• Metabotropic glutamate receptors for new treatments in schizophrenia.

  2012cites this paper
• Investigation on Quantitative Structure Activity Relationships and Pharmacophore Modeling of a Series of mGluR2 Antagonists

  2011cites this paper
• The role of G protein-coupled receptors in the pathology of Alzheimer's disease

  2011cites this paper
• Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators

  2011cites this paper
• Fractionation of Spatial Memory in GRM2/3 (mGlu2/mGlu3) Double Knockout Mice Reveals a Role for Group II Metabotropic Glutamate Receptors at the Interface Between Arousal and Cognition

  2011cites this paper
• Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats

  2011cites this paper
• Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

  2011cites this paper
• Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression

  2011cites this paper
• mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists

  2011cites this paper
• Can small molecules provide truly effective enhancement of cognition? Current achievements and future directions

  2011cites this paper
• Drug targets for cognitive enhancement in neuropsychiatric disorders.

  2011influential citation
• Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.

  2011cites this paper
• Effects of mGluII Receptor Antagonist LY341495 on Nicotine-Sensitized Rats

  2011cites this paper